Cargando…

Patients with heart failure with preserved ejection fraction and low levels of natriuretic peptides

AIMS: Heart failure with preserved ejection fraction (HFpEF) is common and its management remains difficult. B-type natriuretic peptide (BNP) levels are used to diagnose heart failure, and as an entry criterion for inclusion into trials. We investigated a population of HFpEF patients who had been ra...

Descripción completa

Detalles Bibliográficos
Autores principales: Meijers, W. C., Hoekstra, T., Jaarsma, T., van Veldhuisen, D. J., de Boer, R. A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bohn Stafleu van Loghum 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4796061/
https://www.ncbi.nlm.nih.gov/pubmed/26940695
http://dx.doi.org/10.1007/s12471-016-0816-8
_version_ 1782421703022870528
author Meijers, W. C.
Hoekstra, T.
Jaarsma, T.
van Veldhuisen, D. J.
de Boer, R. A.
author_facet Meijers, W. C.
Hoekstra, T.
Jaarsma, T.
van Veldhuisen, D. J.
de Boer, R. A.
author_sort Meijers, W. C.
collection PubMed
description AIMS: Heart failure with preserved ejection fraction (HFpEF) is common and its management remains difficult. B-type natriuretic peptide (BNP) levels are used to diagnose heart failure, and as an entry criterion for inclusion into trials. We investigated a population of HFpEF patients who had been randomised into a study based on clinical parameters, and compared those with low BNP levels to those with elevated BNP levels. METHODS: We examined patients who had been enrolled in the Coordinating study evaluating Outcomes of Advising and Counselling in Heart Failure (COACH), with preserved left ventricular ejection fraction (LVEF ≥ 40 %), and compared those with low BNP (< 100 pg/ml; n = 30) to those with elevated BNP (≥ 100 pg/ml; n = 127). Baseline characteristics, comorbidities, biomarkers, quality of life, and outcome parameters (hospitalisations and death) were compared between the groups. To validate our findings, we repeated all analyses for NT-proBNP (< 300 pg/ml and ≥ 300 pg/ml). RESULTS: Patients were similar with regard to most clinical characteristics (including age, sex, and LVEF), biomarkers, and comorbidities. In contrast, patients with a low BNP had higher body mass index levels (31 kg/m(2) vs. 27 kg/m(2); p < 0.01) and lower cardiac troponin I (9 pg/ml vs. 15 pg/ml; p = 0.02). In addition, these patients were less frequently prescribed diuretics and beta-blockers. No differences in quality of life, heart failure related symptoms and the primary and secondary outcomes were observed between these groups. These observations were confirmed for NT-proBNP. CONCLUSION: Among the patients with clinically diagnosed HFpEF, those with low BNP are strikingly similar to those with elevated BNP levels, except for BMI, which was significantly higher in these patients. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s12471-016-0816-8) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4796061
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Bohn Stafleu van Loghum
record_format MEDLINE/PubMed
spelling pubmed-47960612016-04-08 Patients with heart failure with preserved ejection fraction and low levels of natriuretic peptides Meijers, W. C. Hoekstra, T. Jaarsma, T. van Veldhuisen, D. J. de Boer, R. A. Neth Heart J Original Article AIMS: Heart failure with preserved ejection fraction (HFpEF) is common and its management remains difficult. B-type natriuretic peptide (BNP) levels are used to diagnose heart failure, and as an entry criterion for inclusion into trials. We investigated a population of HFpEF patients who had been randomised into a study based on clinical parameters, and compared those with low BNP levels to those with elevated BNP levels. METHODS: We examined patients who had been enrolled in the Coordinating study evaluating Outcomes of Advising and Counselling in Heart Failure (COACH), with preserved left ventricular ejection fraction (LVEF ≥ 40 %), and compared those with low BNP (< 100 pg/ml; n = 30) to those with elevated BNP (≥ 100 pg/ml; n = 127). Baseline characteristics, comorbidities, biomarkers, quality of life, and outcome parameters (hospitalisations and death) were compared between the groups. To validate our findings, we repeated all analyses for NT-proBNP (< 300 pg/ml and ≥ 300 pg/ml). RESULTS: Patients were similar with regard to most clinical characteristics (including age, sex, and LVEF), biomarkers, and comorbidities. In contrast, patients with a low BNP had higher body mass index levels (31 kg/m(2) vs. 27 kg/m(2); p < 0.01) and lower cardiac troponin I (9 pg/ml vs. 15 pg/ml; p = 0.02). In addition, these patients were less frequently prescribed diuretics and beta-blockers. No differences in quality of life, heart failure related symptoms and the primary and secondary outcomes were observed between these groups. These observations were confirmed for NT-proBNP. CONCLUSION: Among the patients with clinically diagnosed HFpEF, those with low BNP are strikingly similar to those with elevated BNP levels, except for BMI, which was significantly higher in these patients. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s12471-016-0816-8) contains supplementary material, which is available to authorized users. Bohn Stafleu van Loghum 2016-03-03 2016-04 /pmc/articles/PMC4796061/ /pubmed/26940695 http://dx.doi.org/10.1007/s12471-016-0816-8 Text en © The Author(s) 2016 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Original Article
Meijers, W. C.
Hoekstra, T.
Jaarsma, T.
van Veldhuisen, D. J.
de Boer, R. A.
Patients with heart failure with preserved ejection fraction and low levels of natriuretic peptides
title Patients with heart failure with preserved ejection fraction and low levels of natriuretic peptides
title_full Patients with heart failure with preserved ejection fraction and low levels of natriuretic peptides
title_fullStr Patients with heart failure with preserved ejection fraction and low levels of natriuretic peptides
title_full_unstemmed Patients with heart failure with preserved ejection fraction and low levels of natriuretic peptides
title_short Patients with heart failure with preserved ejection fraction and low levels of natriuretic peptides
title_sort patients with heart failure with preserved ejection fraction and low levels of natriuretic peptides
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4796061/
https://www.ncbi.nlm.nih.gov/pubmed/26940695
http://dx.doi.org/10.1007/s12471-016-0816-8
work_keys_str_mv AT meijerswc patientswithheartfailurewithpreservedejectionfractionandlowlevelsofnatriureticpeptides
AT hoekstrat patientswithheartfailurewithpreservedejectionfractionandlowlevelsofnatriureticpeptides
AT jaarsmat patientswithheartfailurewithpreservedejectionfractionandlowlevelsofnatriureticpeptides
AT vanveldhuisendj patientswithheartfailurewithpreservedejectionfractionandlowlevelsofnatriureticpeptides
AT deboerra patientswithheartfailurewithpreservedejectionfractionandlowlevelsofnatriureticpeptides